Sectors
TLSI
TriSalus Life Sciences, Inc.
4.95
2 x 3.39
2 x 5.72
bid
ask
+
0.12
2.48%
2 @ 04:00 PM
4.95 +0.00 (0.00%)
| Ytd | -29.08% | |
| 1y | -5.17% |
4.81
day range
5.03
2.20
52 week range
7.95
| Open | 4.85 | Prev Close | 4.83 | Low | 4.81 | High | 5.03 | Mkt Cap | 304.79M |
| Vol | 72.69K | Avg Vol | 300.35K | EPS | -1.33 | P/E | N/A | Forward P/E | -3.50 |
| Beta | 0.43 | Short Ratio | 2.38 | Inst. Own | 17.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.67 | 200-d Avg | 4.82 | 1yr Est | 11.64 |
TLSI News
businesswire.com
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences to Participate in the H.C. Wainwright &
benzinga.com
TriSalus Life Sciences Affirms FY2026 Sales Guidance of $54.000M-$57.000M vs $52.396M Est
TriSalus Life Sciences (NASDAQ:TLSI) affirms FY2026 sales outlook from $54.000 million-$57.000 milli
benzinga.com
TriSalus Life Sciences Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $11.407M Beat $10.267M Estimate
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.16) per share which missed the